IL2 and cutaneous melanoma: Treatment is based on drugs developed for advanced cutaneous melanoma and includes cisplatin, vinblastine, dacarbazine, INF, and interleukin-2, although given the clinical, biologic, and molecular differences, mucosal and cutaneous melanomas may be distinct disease entities [14].